• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NRH:醌氧化还原酶2和NAD(P)H:醌氧化还原酶1保护肿瘤抑制因子p53免受20S蛋白酶体降解,从而导致p53的稳定和激活。

NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.

作者信息

Gong Xing, Kole Labanyamoy, Iskander Karim, Jaiswal Anil K

机构信息

Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030, USA.

出版信息

Cancer Res. 2007 Jun 1;67(11):5380-8. doi: 10.1158/0008-5472.CAN-07-0323.

DOI:10.1158/0008-5472.CAN-07-0323
PMID:17545619
Abstract

Tumor suppressor p53 is either lost or mutated in several types of cancer. MDM2 interaction with p53 results in ubiquitination and 26S proteasomal degradation of p53. Chronic DNA damage leads to inactivation of MDM2, stabilization of p53, and apoptotic cell death. Here, we present a novel MDM2/ubiquitination-independent mechanism of stabilization and transient activation of p53. The present studies show that 20S proteasomes degrade p53. The 20S degradation of p53 was observed in ubiquitin-efficient and -deficient cells, indicating that this pathway of degradation did not require ubiquitination of p53. The cytosolic quinone oxidoreductases [NRH:quinone oxidoreductase 2 (NQO2) and NAD(P)H:quinone oxidoreductase 1 (NQO1)] interacted with p53 and protected p53 against 20S proteasomal degradation. Further studies revealed that acute exposure to radiation or chemical leads to induction of NQO1 and NQO2 that stabilizes and transiently activates p53 and downstream genes. These results suggest that stress-induced NQO1 and NQO2 transiently stabilize p53, which leads to protection against adverse effects of stressors.

摘要

肿瘤抑制因子p53在多种癌症中要么缺失要么发生突变。MDM2与p53相互作用会导致p53的泛素化和26S蛋白酶体降解。慢性DNA损伤会导致MDM2失活、p53稳定以及凋亡性细胞死亡。在此,我们提出一种新的不依赖MDM2/泛素化的p53稳定和瞬时激活机制。目前的研究表明,20S蛋白酶体会降解p53。在泛素高效和缺乏的细胞中均观察到p53的20S降解,这表明这种降解途径不需要p53的泛素化。胞质醌氧化还原酶[NRH:醌氧化还原酶2(NQO2)和NAD(P)H:醌氧化还原酶1(NQO1)]与p53相互作用,并保护p53免受20S蛋白酶体降解。进一步研究表明,急性暴露于辐射或化学物质会导致NQO1和NQO2的诱导,从而稳定并瞬时激活p53及其下游基因。这些结果表明,应激诱导的NQO1和NQO2会瞬时稳定p53,从而保护细胞免受应激源的不利影响。

相似文献

1
NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.NRH:醌氧化还原酶2和NAD(P)H:醌氧化还原酶1保护肿瘤抑制因子p53免受20S蛋白酶体降解,从而导致p53的稳定和激活。
Cancer Res. 2007 Jun 1;67(11):5380-8. doi: 10.1158/0008-5472.CAN-07-0323.
2
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.由NQO1调控的Mdm-2和不依赖泛素的p53蛋白酶体降解
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13125-30. doi: 10.1073/pnas.202480499. Epub 2002 Sep 13.
3
NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.NAD(P)H:醌氧化还原酶1和NRH:醌氧化还原酶2在膀胱癌和卵巢癌中的活性及表达,以及与NQO2外显子3单核苷酸多态性相关的较低的NRH:醌氧化还原酶2活性。
Clin Cancer Res. 2007 Mar 1;13(5):1584-90. doi: 10.1158/1078-0432.CCR-06-1416.
4
NRH:quinone oxidoreductase 2 (NQO2) protein competes with the 20 S proteasome to stabilize transcription factor CCAAT enhancer-binding protein α (C/EBPα), leading to protection against γ radiation-induced myeloproliferative disease.NRH:醌氧化还原酶 2(NQO2)蛋白与 20S 蛋白酶体竞争,以稳定转录因子 CCAAT 增强子结合蛋白α(C/EBPα),从而防止γ辐射引起的骨髓增生性疾病。
J Biol Chem. 2013 Nov 29;288(48):34799-808. doi: 10.1074/jbc.M113.495580. Epub 2013 Oct 19.
5
A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73.肿瘤抑制因子p53和p73的非泛素依赖性蛋白酶体降解机制。
Genes Dev. 2005 Feb 1;19(3):316-21. doi: 10.1101/gad.319905.
6
Ubiquitin-independent degradation: lessons from the p53 model.不依赖泛素的降解:来自p53模型的经验教训。
Isr Med Assoc J. 2006 Apr;8(4):229-32.
7
Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.在乳腺癌细胞中,Ell3通过其对泛素依赖性和非依赖性蛋白酶体降解途径的作用,在顺铂治疗后稳定p53。
Oncotarget. 2015 Dec 29;6(42):44523-37. doi: 10.18632/oncotarget.5972.
8
NAD(P)H:quinone oxidoreductase 1 (NQO1) competes with 20S proteasome for binding with C/EBPα leading to its stabilization and protection against radiation-induced myeloproliferative disease.烟酰胺腺嘌呤二核苷酸(NAD(P)H):醌氧化还原酶 1(NQO1)与 20S 蛋白酶体竞争与 C/EBPα 结合,导致其稳定,并防止辐射诱导的骨髓增生性疾病。
J Biol Chem. 2012 Dec 7;287(50):41608-18. doi: 10.1074/jbc.M112.387738. Epub 2012 Oct 18.
9
Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.天然酚类化合物姜黄素对NAD(P)H:醌氧化还原酶1活性的抑制及p53降解的诱导作用。
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5535-40. doi: 10.1073/pnas.0501828102. Epub 2005 Apr 4.
10
P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1.P53热点突变体通过增加与NAD(P)H:醌氧化还原酶1的结合而对不依赖泛素的降解具有抗性。
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15065-70. doi: 10.1073/pnas.2436329100. Epub 2003 Nov 21.

引用本文的文献

1
3-Arylidene-2-oxindoles as Potent NRH:Quinone Oxidoreductase 2 Inhibitors.3-芳亚甲基-2-氧代吲哚作为有效的 NRH:醌氧化还原酶 2 抑制剂。
Molecules. 2023 Jan 25;28(3):1174. doi: 10.3390/molecules28031174.
2
A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases.对恢复神经退行性疾病中氧化还原稳态和功能性线粒体的替代治疗方法的新见解。
Antioxidants (Basel). 2021 Dec 21;11(1):7. doi: 10.3390/antiox11010007.
3
Insights into the New Cancer Therapy through Redox Homeostasis and Metabolic Shifts.
通过氧化还原稳态和代谢转变洞察新型癌症疗法
Cancers (Basel). 2020 Jul 7;12(7):1822. doi: 10.3390/cancers12071822.
4
NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma.NQO1 通过抑制蛋白酶体介导的 SIRT6 降解增强肝癌细胞凋亡逃逸并上调 XIAP。
Cell Commun Signal. 2019 Dec 16;17(1):168. doi: 10.1186/s12964-019-0491-7.
5
Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity.人类 NQO1 的癌症相关变异体:对抑制剂结合和协同性的影响。
Biosci Rep. 2019 Sep 6;39(9). doi: 10.1042/BSR20191874. Print 2019 Sep 30.
6
Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis.对伴有肝转移的结直肠癌患者癌组织中长链非编码RNA(lncRNA)表达的全基因组分析。
Cancer Med. 2016 Jul;5(7):1629-39. doi: 10.1002/cam4.738. Epub 2016 May 11.
7
Regulating the 20S proteasome ubiquitin-independent degradation pathway.调控20S蛋白酶体非泛素依赖性降解途径。
Biomolecules. 2014 Sep 23;4(3):862-84. doi: 10.3390/biom4030862.
8
Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase(1.).人类NAD(P)H:醌氧化还原酶(1)中单个氨基酸交换导致的天然结构坍塌。
FEBS J. 2014 Oct;281(20):4691-4704. doi: 10.1111/febs.12975. Epub 2014 Sep 19.
9
Identification of NAD(P)H quinone oxidoreductase activity in azoreductases from P. aeruginosa: azoreductases and NAD(P)H quinone oxidoreductases belong to the same FMN-dependent superfamily of enzymes.铜绿假单胞菌偶氮还原酶中NAD(P)H醌氧化还原酶活性的鉴定:偶氮还原酶和NAD(P)H醌氧化还原酶属于同一依赖黄素单核苷酸的酶超家族。
PLoS One. 2014 Jun 10;9(6):e98551. doi: 10.1371/journal.pone.0098551. eCollection 2014.
10
The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties.人类 NRH-醌氧化还原酶 2(NQO2)的两种常见多态形式具有不同的生化特性。
FEBS Lett. 2014 May 2;588(9):1666-72. doi: 10.1016/j.febslet.2014.02.063. Epub 2014 Mar 12.